Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity.
about
A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System.Pantoprazole decreases cell viability and function of human osteoclasts in vitroProton Pump Inhibitors and the Risk of Osseointegrated Dental Implant Failure: A Cohort Study.Bone Anabolic Effects of Soluble Si: In Vitro Studies with Human Mesenchymal Stem Cells and CD14+ Osteoclast Precursors.Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis.Adverse skeletal effects of drugs - beyond Glucocorticoids.Hyperparathyroidism Associated with Long-Term Proton Pump Inhibitors Independent of Concurrent Bisphosphonate Therapy in Elderly Adults.Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice.Editorial: Non-breaking news! High-dose PPIs likely do not cause fractures.Effects of omega-3 fatty acids on bone turnover markers in postmenopausal women: systematic review and meta-analysis.Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.Load-sharing through elastic micro-motion accelerates bone formation and interbody fusion.Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae.Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort StudyProton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
P2860
Q33441225-1F0227BE-556B-4DA8-82E7-281F348D404AQ33912042-84758EE6-EBE9-45D9-8657-9494E6D12C2FQ35271665-24A98089-EC78-4DD7-BF9D-76D334688C47Q36170237-3AE3E486-0DDD-4219-BB07-0AA5FB4388D7Q36424174-D29FFB63-CAAB-499D-9457-17D34195EA58Q36437727-D3A4D6C2-95AF-4317-9AFA-C6B8AFF5C36DQ38231316-6A868B0A-8A79-4DDA-8267-78A8F77CF2F5Q38594682-EBAB1FF4-1A71-4835-A50B-A123C83C73F5Q38870220-80E8EFFA-B0B2-4602-8DB9-1B8088588302Q40475429-270BBF97-1DF5-4424-AE24-169296AC5D57Q41707081-AD90B030-9E79-437F-B8DB-695E7E1CE188Q48144693-31C64994-5659-4460-9FA9-A8E9AB69219BQ48183681-B6496918-C989-42B0-9047-94947BCC6809Q48186337-7918981E-FBC0-4D44-9496-68940D3D396EQ49922945-35E5C1EF-98F4-43C3-9DEB-2492BD5CC3EFQ51578494-143B381B-5075-4853-9222-D22B556939E8Q58779200-91000477-41CD-4164-8B68-06B1C93A95E1Q58780145-E107CCFC-B77B-4560-A185-CEA5A5015EE6
P2860
Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@en
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@nl
type
label
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@en
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@nl
prefLabel
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@en
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@nl
P2093
P2860
P356
P1433
P1476
Dose-dependent inhibitory effe ...... nd osteoblastic cell activity.
@en
P2093
João Costa-Rodrigues
Sandra Lopes
Sónia Teixeira
P2860
P304
P356
10.1111/FEBS.12478
P407
P577
2013-09-05T00:00:00Z